These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 18499275)

  • 21. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
    Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
    Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An ELISA based on the repeated foot-and-mouth disease virus 3B epitope peptide can distinguish infected and vaccinated cattle.
    Gao M; Zhang R; Li M; Li S; Cao Y; Ma B; Wang J
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1271-9. PubMed ID: 22207215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplexed detection of antibodies to nonstructural proteins of foot-and-mouth disease virus.
    Perkins J; Clavijo A; Hindson BJ; Lenhoff RJ; McBride MT
    Anal Chem; 2006 Aug; 78(15):5462-8. PubMed ID: 16878883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of non-structural protein-antibody detecting ELISAs for foot-and-mouth disease sero-surveillance under intensive vaccination.
    Sharma GK; Mohapatra JK; Mahajan S; Matura R; Subramaniam S; Pattnaik B
    J Virol Methods; 2014 Oct; 207():22-8. PubMed ID: 24996132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotype-independent detection of foot-and-mouth disease virus.
    Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
    J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
    Kumar N; Sharma R; Kakker NK
    Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of non-structural protein enzyme-linked immunosorbent assays for the detection of serum antibodies against foot-and-mouth disease virus in a target population in New Zealand.
    Kittelberger R; Mackereth GF; Sewell M; Keall J; Clough R; Pigott C; O'Keefe JS
    N Z Vet J; 2008 Oct; 56(5):227-32. PubMed ID: 18836503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the solid phase competition ELISA for detecting antibodies against the six foot-and-mouth disease virus non-O serotypes.
    Li Y; Swabey KG; Gibson D; Keel PJ; Hamblin P; Wilsden G; Corteyn M; Ferris NP
    J Virol Methods; 2012 Aug; 183(2):125-31. PubMed ID: 22561986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of antibody to the foot-and-mouth disease virus (FMDV) non-structural polyprotein 3ABC in sheep by ELISA.
    Armstrong RM; Cox SJ; Aggarwal N; Mackay DJ; Davies PR; Hamblin PA; Dani P; Barnett PV; Paton DJ
    J Virol Methods; 2005 May; 125(2):153-63. PubMed ID: 15794985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody.
    Sørensen KJ; de Stricker K; Dyrting KC; Grazioli S; Haas B
    Arch Virol; 2005 Apr; 150(4):805-14. PubMed ID: 15645377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-species indirect ELISA for detection of non-structural protein 3ABC specific antibodies to foot-and-mouth disease virus.
    Hosamani M; Basagoudanavar SH; Tamil Selvan RP; Das V; Ngangom P; Sreenivasa BP; Hegde R; Venkataramanan R
    Arch Virol; 2015 Apr; 160(4):937-44. PubMed ID: 25623051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and use of a biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus.
    Clavijo A; Zhou EM; Hole K; Galic B; Kitching P
    J Virol Methods; 2004 Sep; 120(2):217-27. PubMed ID: 15288965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality assurance/quality control of foot and mouth disease solid phase competition enzyme-linked immunosorbent assay--Part I. Quality assurance: development of secondary and working standards.
    Goris N; De Clercq K
    Rev Sci Tech; 2005 Dec; 24(3):995-1004. PubMed ID: 16642770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.
    Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N
    Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of continuous results to compare ELISAs for the detection of antibodies to non-structural proteins of foot-and-mouth disease virus.
    Dekker A; Sammin D; Greiner M; Bergmann I; Paton D; Grazioli S; de Clercq K; Brocchi E
    Vaccine; 2008 May; 26(22):2723-32. PubMed ID: 18450336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
    Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
    Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease research.
    Willems T; Lefebvre DJ; Neyts J; De Clercq K
    J Virol Methods; 2011 Apr; 173(1):108-14. PubMed ID: 21295609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus.
    Brocchi E; Bergmann IE; Dekker A; Paton DJ; Sammin DJ; Greiner M; Grazioli S; De Simone F; Yadin H; Haas B; Bulut N; Malirat V; Neitzert E; Goris N; Parida S; Sørensen K; De Clercq K
    Vaccine; 2006 Nov; 24(47-48):6966-79. PubMed ID: 16753241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
    Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
    Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.